Global Health Matters

10 July 2019 - By Kawaldip Sehmi
Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO) talks to IFPMA about why the Essential Medicines List is important for patients. What does the addition of new medicines on the 2019 EML update mean for patients? The inclusion of any medicine, including innovative and specialty medicines, on ...
Read More
27 June 2019 - By Abraham Palache
This blog was originally published on Health Awareness Value of Vaccines 2019 campaign on 27 June 2019. Influenza is a highly infectious disease that usually strikes during the winter season. Globally, it causes an estimated one billion cases of influenza, resulting in 290,000 to 650,000 deaths per year. A person ...
Read More
11 June 2019 - By Fumie Griego & Githinji Gitahi
This blog was originally published on Health Policy Watch on 7 June 2019. The first-ever United Nations High-Level Meeting (UNHLM) on Universal Health Coverage (UHC), scheduled for 23 September 2019, will soon be upon us. The sense of urgency in preparing for this historic milestone in achieving global health progress ...
Read More
20 May 2019 - By Adebayo Alonge
Adebayo Alonge, pharmacist and entrepreneur, talks to IFPMA about why it is important to bring universal health coverage (UHC) to his native Africa, especially rural areas, how to build up local healthcare systems, foster home-grown hi-tech pharma – and fight quack medicines.   You have been an avid global health ...
Read More
Symbolic scale of the stones on sea background closeup. Concept of harmony and balance. work-life, emotional balance
13 May 2019 - By Thomas B. Cueni
This blog was originally published on Health Policy Watch on 10 May 2019. “Most of us can probably agree that innovation is meaningless if it does not reach patients. At the same time, a Fair Price must strike a balance between a price that is affordable for health systems and ...
Read More
17 April 2019 - By Thomas B. Cueni
This article was originally published by Buisness Day  on April 16, 2019. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) says health activists’ call last week for greater transparency on medicine prices could backfire, and drive up drug costs in low and middle-income countries. Activists stepped up their campaign ahead ...
Read More
16 April 2019 - By Lois Privor-Dumm
This article was originally published by STAT on April 16, 2019. Vaccines are credited with averting millions of child deaths in the last decade, with most countries offering infants the basic protection of immunization against more than 10 serious diseases. But the risk of infectious disease does not end with ...
Read More
Group of business people holding a jigsaw puzzle pieces. Business solution integration concept. Multi ethnic group. Close up of hands
9 April 2019 - By Thomas B. Cueni
As the number of infections resistant to antimicrobial drugs continues to rise around the world, and with it their huge human and financial toll, we urgently need new ways to preserve the effectiveness of existing antibiotics and to develop much-needed new ones. Creating state-run or publicly owned pharmaceutical companies, an ...
Read More
9 April 2019 - By Greg Perry
More and more, Africans and their leaders, public and private, can see that good health is a key, perhaps the key, to a healthy and sustainable economy. And that universal health coverage (UHC), quality healthcare for all, can unlock the huge potential of 1.3bn people as I and others heard ...
Read More
3 April 2019 - By Heidi Larson
The announcement by Facebook that it will no longer allow anti-vaccine advertisements on its platform is welcome as measles cases surge in the U.S. Pacific Northwest and double in Europe. But this measure alone is not enough to address the growing global spread of “vaccine hesitancy” and rising rates of disease and death caused by undervaccination. Facebook ...
Read More
21 March 2019 - By Kate Dodson
You’ve seen the alarming headlines from around the world: Asia, Europe, Africa, South America, and North America have seen the highest number of measles outbreaks in decades, and this disease once thought eliminated in many parts of the world is coming back with a vengeance. Why are we seeing such staggering rates of infections — and ...
Read More
8 March 2019 - By Unjela Kaleem
This blog was first published on Pharma Boardroom on 8 March 2019. The jury is still out there regarding the impact of technological advancements on our overall life styles, but it’s hard to deny the positive impact technology has had on women’s social, political, economic and religious status in societies ...
Read More
7 March 2019 - By Thomas B. Cueni
This oped was first published on Pharma Focus Asia on 7 March 2019. Seventy years ago, average life expectancy globally was 47; today it is 72. Seventy years ago, 50 million people worldwide were infected with smallpox; today none. The disease is eradicated. Thanks to initiatives such as Gavi (the ...
Read More
5 March 2019 - By Laetitia Bigger
Laetitia Bigger, Director, Vaccines Policy at IFPMA, spoke with Jenny Sia, Director of Corporate Responsibility at the Pfizer Foundation, about innovations in mHealth technology that are helping to increase access to vaccines. Jenny leads global health grant making and impact investing for the Pfizer Foundation, a charitable organization aiming to ...
Read More
7 February 2019 - By Fumie Griego
Since the start of the 21st century, Gavi, the Vaccine Alliance, has transformed lives, preventing more than 10 million potential deaths. In 2002, when AIDS, TB and malaria appeared unstoppable, the Global Fund to fight these three fatal diseases was created and since then has saved millions of lives – ...
Read More
1 2 3 8